Weight-adjusted and activated clotting time-guided heparinization might reduce the postprocedural hemorrhage in percutaneous transluminal angioplasty for acute middle cerebral artery occlusion.
Ai-Hsien
AH
Li
Lung
L
Chan
Yiu-Tong
YT
Chu
Kuan-Ming
KM
Chiu
Shu-Hsun
SH
Chu
D000328:Adult; D000800:Angioplasty, Balloon / Q000009:adverse effects*; D000925:Anticoagulants / Q000008:administration & dosage* / Q000627:therapeutic use; D001835:Body Weight; D002543:Cerebral Hemorrhage / Q000209:etiology*; D005260:Female; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000628:therapy*; D014914:Whole Blood Coagulation Time
D000925:Anticoagulants; D006493:Heparin